Effect of PI-3K Inhibitor on Erythroid Colony Growth
LY294002 Concentration (μmol/L) . | Total . | CFU-E . | Small Erythroid . |
---|---|---|---|
0 (IMDM) | 76.3 ± 3.2 | 72.0 ± 3.0 | 4.3 ± 1.2 |
0 (0.1% DMSO) | 91.7 ± 1.5 | 83.7 ± 2.3 | 8.0 ± 3.6 |
1 | 78.3 ± 14.5 | 68.3 ± 9.4 | 10.0 ± 6.3 |
10 | 36.3 ± 4.6* | 30.3 ± 3.5† | 6.0 ± 2.6 |
20 | 34.7 ± 5.5† | 23.3 ± 2.0† | 8.0 ± 2.6 |
50 | 3.0 ± 2.0† | 0† | 3.0 ± 2.0 |
100 | 0† | 0† | 0 |
LY294002 Concentration (μmol/L) . | Total . | CFU-E . | Small Erythroid . |
---|---|---|---|
0 (IMDM) | 76.3 ± 3.2 | 72.0 ± 3.0 | 4.3 ± 1.2 |
0 (0.1% DMSO) | 91.7 ± 1.5 | 83.7 ± 2.3 | 8.0 ± 3.6 |
1 | 78.3 ± 14.5 | 68.3 ± 9.4 | 10.0 ± 6.3 |
10 | 36.3 ± 4.6* | 30.3 ± 3.5† | 6.0 ± 2.6 |
20 | 34.7 ± 5.5† | 23.3 ± 2.0† | 8.0 ± 2.6 |
50 | 3.0 ± 2.0† | 0† | 3.0 ± 2.0 |
100 | 0† | 0† | 0 |
Day 8 cells were plated into 0.25 mL serum-free fibrin clots at a concentration of 250 cells/clot with EPO at 2 U/mL. After 7 days of incubation, the clots were fixed and stained with benzidine-hematoxylin. The mean ± SD of triplicates is shown. Statistical analysis was performed using Scheffe’s F post hoc test.
P < .01, decrease v 0.1% DMSO.
P < .001, decrease v 0.1% DMSO.